In this regard, several studies have proposed that pharmacological modulation of plasmalemmal NCX could attenuate the ionic imbalance in cardiac cells, reducing the incidence of severe arrhythmias caused by CIR [17,18,22,40]. Here, TLX2 is linked to Arrhythmia.